The trial added 177Lu-PNT2002 to stereotactic body radiation therapy (SBRT) and found that median progression-free survival ...

Cardiovascular disease is the leading cause of death in patients with prostate cancer. Androgen-deprivation therapy (ADT), a commonly used hormone treatment for prostate cancer, can contribute to ...

Adding the targeted radioactive drug 177Lu-PNT2002 to stereotactic body radiation therapy, or SBRT, may help keep recurrent ...

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

Prostate cancer remains one of the most common malignancies in men worldwide, ranking as the second most prevalent cancer and ...

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that while traditional pathological features used to classify aggressive prostate cancer—such as ...

Please provide your email address to receive an email when new articles are posted on . A genetic test that identifies the PAM50 biomarker predicted which patients with recurrent prostate cancer would ...

SAN FRANCISCO — A genomic test can identify patients with recurrent prostate cancer who are most likely to benefit from adding hormone therapy to secondary radiotherapy, according to findings ...

A study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that most of the benefits of androgen deprivation therapy (ADT) for prostate cancer occur within the first ...

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that while traditional pathological features used to classify aggressive prostate cancer -such as ...

Prostate tumors can rewire amino acid metabolism to override the normal brakes on cholesterol production, a process that may fuel hormone therapy resistance, according to a study by Weill Cornell ...

Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients By Dennis Thompson HealthDay ReporterMONDAY, March 2, 2026 (HealthDay News) — Some men who’ve had surgery for prostate cancer can ...